首页> 外文OA文献 >Multicenter Comparison of the Sensititre YeastOne Colorimetric Antifungal Panel with the NCCLS M27-A2 Reference Method for Testing New Antifungal Agents against Clinical Isolates of Candida spp.
【2h】

Multicenter Comparison of the Sensititre YeastOne Colorimetric Antifungal Panel with the NCCLS M27-A2 Reference Method for Testing New Antifungal Agents against Clinical Isolates of Candida spp.

机译:敏感的YeastOne比色抗真菌试剂盒与NCCLS M27-A2参考方法的多中心比较,用于测试针对新型念珠菌的新型抗真菌剂。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

A multicenter (three centers) study compared MICs obtained by the Sensititre YeastOne Colorimetric Antifungal plate to reference microdilution broth (NCCLS M27-A2 document) MICs of three new triazoles (posaconazole, ravuconazole, and voriconazole) and the echinocandin caspofungin acetate for 100 isolates of Candida spp. In addition, amphotericin B and fluconazole were tested as control drugs. Colorimetric MICs of caspofungin and amphotericin B corresponded to the first blue well (no growth), and MICs of the other agents corresponded to the first slightly purple or blue well. Two comparisons of MIC pairs by the two methods were evaluated: 24-h colorimetric MICs were compared to NCCLS MICs at 24 and at 48 h. The interlaboratory reproducibility of YeastOne and reference MICs was also examined. The best performance of the YeastOne plate was with 24-h MICs (overall, 95 to 99% agreement) for all the species and antifungal agents. These results suggest the potential value of the YeastOne plate for use in the clinical laboratory for the four new antifungal agents evaluated.
机译:一项多中心(三个中心)研究比较了Sensititre YeastOne比色抗真菌平板获得的MIC与参考微稀释液(参考NCCLS M27-A2)中三种新三唑(posaconazole,ravuconazole和voriconazole)和echinocandin caspofungin醋酸盐的100分离物的MIC。念珠菌属此外,还测试了两性霉素B和氟康唑作为对照药物。卡泊芬净和两性霉素B的比色MIC对应于第一个蓝色孔(无生长),其他试剂的MIC对应于第一个浅紫色或蓝色孔。评估了两种方法对MIC对的两次比较:在24和48 h将24小时比色MIC与NCLLS MIC进行了比较。还检查了YeastOne和参考MIC在实验室之间的可重复性。 YeastOne平板的最佳性能是对所有物种和抗真菌剂使用24小时MIC(总体而言,一致性为95%到99%)。这些结果表明YeastOne平板在临床实验室中用于评估的四种新抗真菌剂的潜在价值。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号